Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress
Zhipei Sang, Keren Wang, Jianghong Dong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114464-114464
Closed Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Zdeněk Fišar
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1676-1676
Open Access | Times Cited: 51
Preclinical Models for Alzheimer’s Disease: Past, Present, and Future Approaches
Ansab Akhtar, Shraddha Manish Gupta, Shubham Dwivedi, et al.
ACS Omega (2022) Vol. 7, Iss. 51, pp. 47504-47517
Open Access | Times Cited: 41
Targeting protein kinases for the treatment of Alzheimer's disease: Recent progress and future perspectives
Zhijia Li, Bo Yin, Shuangqian Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115817-115817
Closed Access | Times Cited: 26
New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease
Botond Penke, Mária Szűcs, Ferenc Bogár
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5383-5383
Open Access | Times Cited: 22
Identification of DprE1 inhibitors for tuberculosis through integrated in-silico approaches
Swagatika Dash, Ekta Rathi, Avinash Kumar, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Moroccan natural products for multitarget-based treatment of Alzheimer’s disease: A computational study
Fatima Zahra Guerguer, Amal Bouribab, El Mehdi Karim, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313411-e0313411
Open Access
Design, synthesis and evaluation of quinoline- O -carbamate derivatives as multifunctional agents for the treatment of Alzheimer’s disease
Hongsong Chen, Jing Mi, Sen Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 19
Development of the “hidden” multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease
Rui Chen, Xinjuan Li, Hongsong Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115253-115253
Closed Access | Times Cited: 16
Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases
Yu Xiang, Swapna Naik, Liyun Zhao, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1404-1445
Closed Access | Times Cited: 6
Co‐Assembled Nanoparticles toward Multi‐Target Combinational Therapy of Alzheimer's Disease by Making Full Use of Molecular Recognition and Self‐Assembly
Wen‐Bo Li, Linlin Xu, Si‐Lei Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 28
Closed Access | Times Cited: 5
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 5
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease
Zhonghua Li, Zhenqiang Zhang, Bin Yu
Journal of Medicinal Chemistry (2025)
Closed Access
Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD
Yuting Li, Qiyao Zhang, Xinxin Wang, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108245-108245
Closed Access
TMF Attenuates Cognitive Impairment and Neuroinflammation by Inhibiting the MAPK/NF-κB Pathway in Alzheimer’s Disease: A Multi-Omics Analysis
Yonglin Liu, Xi Xu, Xiao-Ming Wu, et al.
Marine Drugs (2025) Vol. 23, Iss. 2, pp. 74-74
Open Access
Donepezil-Based Rational Design of N-Substituted Quinazolinthioacetamide Candidates as Potential Acetylcholine Esterase Inhibitors for the Treatment of Alzheimer’s Disease: In vitro and In vivo Studies
Ahmed A. Al‐Karmalawy, Ahmed F. Mohamed, Heba Nasr Shalaby, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Artificial intelligence-driven development of natural multi-target derivatives with BuChE inhibitory activity for treating Alzheimer's disease
Qiyao Zhang, Yuting Li, Qunhua Jin, et al.
Chinese Chemical Letters (2025), pp. 110964-110964
Closed Access
Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer’s disease
Zhipei Sang, Shuheng Huang, Wanying Tan, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Development of novel melatonin-isatin hybrids as multifunctional agents for Alzheimer’s disease
Yingying Zhong, Jun-Ze Deng, Qin Wang, et al.
Molecular Diversity (2025)
Closed Access
Discovery of novel theophylline derivatives bearing tetrazole scaffold for the treatment of Alzheimer's disease
Nguyễn Viết Hưng, Le Quoc Tien, Linh Hoang Vu, et al.
RSC Advances (2025) Vol. 15, Iss. 9, pp. 6994-7003
Open Access
Structure-based discovery of dual pathway inhibitors for SARS-CoV-2 entry
Haofeng Wang, Qi Yang, Xiaoce Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Systematic Designing and Optimization of Polymeric Nanoparticles Using Central Composite Design: A Novel Approach for Nose-to-Brain Delivery of Donepezil Hydrochloride
Yogesh Garg, Mohit Kumar, Gajanand Sharma, et al.
Journal of Cluster Science (2023) Vol. 35, Iss. 4, pp. 1007-1019
Closed Access | Times Cited: 12
Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease
Ana Matošević, Dejan Opsenica, Marta Spasić, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110620-110620
Closed Access | Times Cited: 11
Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease
Xueyan Liu, Chuanyu Yu, Yuxing Yao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115120-115120
Closed Access | Times Cited: 10
Discovery of indole-piperazine derivatives as selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting activities and neuroprotective activities
Ting Liang, Zhao Xie, Baiyun Dang, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 81, pp. 129148-129148
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top